瑞士乳杆菌发酵乳对骨强度的影响

利用8月龄SD去卵巢大鼠研究瑞士乳杆菌发酵乳对骨强度可能产生的影响.将患有骨质疏松症的大鼠.随机分为6组(每组8只),每天喂1次瑞士乳杆茵发酵乳,对照组饮用水、脱脂乳、普通酸乳和瑞士乳杆菌发酵乳乳清多肽提取物,实验观察10周.用瑞士乳杆菌发酵乳长期喂养大鼠,能明显增加骨骼的承栽能力.提高骨骼抵抗骨折的能力.     

瑞士乳杆菌发酵乳对骨密度的影响研究

利用8月龄SD去卵巢大鼠研究瑞士乳杆菌发酵乳对骨密度和骨矿物质含量可能产生的影响。将患有骨质疏松症的大鼠，随机分为5组（每组8只），每天喂一次瑞士乳杆菌发酵乳，对照组饮用水、脱脂乳和普通酸乳，实验观察10周。用双能X射线骨密度测量仪测定骨密度及骨矿物质含量。右股骨用于测量骨密度指标，左股骨测量骨钙含量。瑞士乳杆菌发酵乳相对于水和酸奶而言，能够明显的增加骨密度和骨矿物质的含量，饮用瑞士乳杆菌发酵乳组大鼠的骨密度及骨矿物质含量的平均值较脱脂乳、普通酸奶组高，但统计无显著性差异。用瑞士乳杆菌发酵乳长期喂养大鼠，能明显增加其骨密度、骨矿物质含量和增加骨骼的承载能力，提高骨骼抵抗骨折的能力。     

瑞士乳杆菌发酵乳的研究

本文选用瑞士乳杆菌作为发酵剂菌种制作酸奶,利用其产酸产粘特性好的特点,研究了在乳中的生长特性。在12％的脱脂复原乳,在40度下培养所制得的酸奶凝乳时间为4.3h,凝乳时PH为4.46,酸度为87°T,经过后熟,凝乳质地光滑,口感细腻,无乳清分离和不良发酵气味,活茵数4.1×109个/mL。利用喷雾干燥设备制得的酸奶粉活菌数大于109个/g,经过活化可作为酸奶的发酵剂和含有活性乳酸菌食品的配料。     

瑞士乳杆菌发酵牛乳产生抗ACE活性条件的优化

本实验探讨了发酵条件对瑞士乳杆菌发酵牛乳产生抗ACE活性的影响。在单因素试验的基础上,进行正交试验,得出能产生较高抗ACE活性的最佳工艺条件是:发酵温度为37℃,发酵时间为12h,无脂乳固形物浓度12%(W/V)。     

瑞士乳杆菌与干酪乳杆菌在脱脂乳中发酵特性的研究

研究了瑞士乳杆菌(Lh134)和干酪乳杆菌(Lc134)单独与组合在脱脂乳中发酵32 h的pH、发酵乳酸度值、活菌数和氨基酸态氮变化.结果表明,Lh134在脱脂乳中发酵速度比Lc134快,Lh134和Lc134组合在脱脂乳中的发酵能力高过二者单株发酵,发酵结束时pH下降至3.90,发酵乳酸度达到281.30°T,活菌数...     

酪蛋白水解物对瑞士乳杆菌生长的影响

利用胰蛋白酶水解酪蛋白,以水解物对瑞士乳杆菌增殖效果为指标,优化水解条件,并研究最佳增殖效果。 结果表明：胰蛋白酶水解酪蛋白的最佳水解条件为水解温度37℃、底物质量分数5%、酶与底物质量比1:600、pH8.0,此条件下制备的水解产物添加量为1g/100mL 时对瑞士乳杆菌生长增殖效果最好,而添加量大于4g/100mL 时,对瑞士乳杆菌生长呈现抑制作用。     

添加瑞士乳杆菌对发酵牦牛乳抗氧化能力的影响

添加瑞士乳杆菌（Lactobacillus helveticus,Lh）与嗜热链球菌-德氏乳杆菌保加利亚亚种发酵剂（Streptococcus thermophilus-Lactobacillus bulgaricus,Y）单独或共培发酵,研究Lh不同接种量对牦牛乳的发酵特性、以及发酵牦牛乳的抗氧化能力与肽含量及蛋白水解活力之间的关系。研究发现,Lh与Y混合发酵能使牦牛乳更快凝乳,凝乳时间为2.67 h;在整个冷藏期间,DPPH自由基清除能力和羟自由基清除能力分别与肽含量呈极显著相关（P<0.01）,均表现为先上升后下降的趋势,于第14天达到最大值（P<0.05）,其中5%Lh-Y组的DPPH自由基清除能力最强,为93.95%,同时该组样品的羟自由基清除能力最强,为81.83%;Fe2+螯合能力表现为下降趋势,分别与肽含量、蛋白水解活力呈极显著相关（P<0.01）,5%Lh组样品的螯合能力最强;还原能力表现为上升趋势,与蛋白水解活力呈显著相关（P<0.05）,5%Lh-Y组的还原能力最强。结果表明,Lh与Y混合培养能够显著提高发酵牦牛乳样品的抗氧化能力,瑞士乳杆...     

瑞士乳杆菌与干酪乳杆菌在不同原料中的发酵特性研究

研究了瑞士乳杆菌和干酪乳杆菌单独与组合,以及与嗜热链球菌和保加利亚乳杆菌组合在纯牛乳、纯豆乳和混合乳中发酵12h后pH值和酸度值变化,以此来说明它们在3种原料中的生长情况.结果表明,瑞士乳杆菌在纯牛乳和混合乳中产酸能力很强,在纯豆乳中产酸能力不够强,生长不够好;干酪乳杆菌在纯豆乳中生长产酸能力比瑞士乳杆菌强;研究还得出瑞士乳杆菌和干酪乳杆菌组合,以及他们分别与嗜热链球菌和保加利亚乳杆菌组合在纯豆乳生长产酸能力相当.     

瑞士乳杆菌对小鼠肠道微生物区系的影响

本实验探讨瑞士乳杆菌对小鼠肠道微生物区系的影响,分析小鼠灌喂益生菌后肠道内各种微生物变化规律。研究将小鼠分成4组,日食对照组、生理盐水对照组、瑞士乳杆菌灌喂组和大肠杆菌灌喂组,连续灌喂15d,采集小鼠粪便利用选择性培养基对不同组别的小鼠肠道菌群作平板计数分析。研究结果表明,瑞士乳杆菌灌喂组与日食组和生理盐水组相比其肠道中乳酸菌类、双歧杆菌类、肠杆菌类、大肠杆菌类差异极显著（p〈O．01）,肠球菌类含量具有显著性差异（p〈0．05）;大肠杆菌灌喂组其肠道中乳酸菌类、双歧杆菌类、肠杆菌类、大肠杆菌类含量与对照组相比具有显著性差异（p〈0．05）,而肠球菌类的分析结果显示变化差异不显著。研究证实了瑞士乳杆菌能够促进小鼠肠道内有益菌的显著增殖,而对肠道内过路菌和可疑致病菌均有一定的抑制作用,表明灌喂瑞士乳杆菌对小鼠肠道微生物区系具有一定的调节作用。     

瑞士乳杆菌TUST-005发酵乳抗菌特性研究

实验对瑞士乳杆菌TUST-005进行抗菌特性研究。采用挖洞琼脂扩散法对该菌发酵液进行体外抗菌实验，并进行了乳酸、pH值、过氧化氢、以及蛋白酶类物质对抗菌作用影响因素实验。以及该菌与保加利亚乳杆菌、嗜热链球菌和丁二酮链球菌的拮抗实验。结果发现，本菌株对大肠杆菌、沙门氏菌、金黄色葡萄球菌有抗菌效果；由相关研究结果推测本菌株抗菌作用产生的主要原因是产生了小分子的抗菌肽，其抗菌效果不受胃蛋白酶、胰蛋白酶作用的影响，随着pH值的升高而减弱。此外，该菌对上述3种乳酸菌无拮抗作用。     

瑞士乳杆菌和嗜酸乳杆菌的益生免疫特性的研究

以瑞士乳杆菌KLDS 1.8701和嗜酸乳杆菌KLDS AD1、KLDS AD2为研究对象,详细研究了它们对体外模拟人工胃肠道的耐受性,并评估了三株乳杆菌对小鼠脾淋巴细胞增殖活性的影响,初步探讨了三株乳杆菌的免疫活性。结果表明,三株乳杆菌对人工胃液、人工肠液、胆汁盐环境具有很好的耐受性,瑞士乳杆菌KLDS 1.8701和嗜酸乳杆菌KLDS AD1较强于嗜酸乳杆菌KLDS AD2。乳杆菌对脾淋巴细胞增殖活性的作用表现出明显的量效关系,活菌数为107CFU/mL时,对脾淋巴细胞活性影响大小为KLDS AD1>KLDS 1.8701>KLDS AD2;KLDS 1.8701对脾淋巴细胞的增殖具有很好的促进作用,只有当KLDS AD1的活菌数达到107CFU/mL时才具有促进作用,而KLDS AD2没有促进作用。      

Effects of Lactobacillus helveticus TUST005 fermented milk on bone parameters in rats

The effects on bone parameters were investigated using ovariectomized rats and their control ones fed with water, skim milk, sour milk, Lactobacillus helveticus TUST005 fermented milk and whey filtrate of the L. helveticus TUST005 fermented milk for 10-week interventions, respectively. Our results indicated that the ovariectomized rats are considered a suitable model for osteoporosis. The L. helveticus TUST005 fermented milk significantly increased bone mineral density, bone mineral content, the maximal load of bone and decreased bone loss compared to sour milk, and whey filtrate of the L. helveticus TUST005 fermented milk has a higher influence on bone than the fermented milk.     

Angiotensin I‐converting enzyme inhibitory peptides in skim milk fermented with Lactobacillus helveticus 130B4 from camel milk in Inner Mongolia,China

BACKGROUND: Angiotensin I‐converting enzyme (ACE) is a dipeptidyl carboxypeptidase associated with the regulation of blood pressure. ACE inhibition results in a lowering of blood pressure. Lactic acid bacteria are known to produce ACE inhibitors during fermentation. Fermented camel milk is the main traditionally fermented dairy food for desert nomads. The beneficial effects of fermented camel milk, which include the prevention of such diseases and conditions as gastroenteritis, tuberculosis and hypertension, have been demonstrated experimentally. RESULTS: ACE inhibitory activity was observed in fermented milk containing Lactobacillus helveticus 130B4, a strain isolated from traditionally fermented camel milk. The peptide that inhibited ACE was purified from the fermented milk by reverse‐phase high‐performance liquid chromatography. The amino acid sequence of the peptide was identified as Ala‐Ile‐Pro‐Pro‐Lys‐Lys‐Asn‐Gln‐Asp (IC₅₀ = 19.9 µmol L^?1). The same Ala‐Ile‐Pro‐Pro‐Lys‐Lys‐Asn‐Gln‐Asp sequence was found in κ‐casein (κ‐CN) f107–115 from milk. The inhibitory activity of this nonapeptide (κ‐CN f107–115) was almost preserved even after successive digestion with pepsin, trypsin and chymotrypsin. Furthermore, the inhibitory activity of the purified peptide was completely preserved after heat treatment at 100 °C for 20 min. CONCLUSION: The fermented milk prepared with Lactobacillus helveticus 130B4 contained an ACE inhibitory peptide, κ‐CN 107–115. This fermented milk was expected to have anti‐hypertensive effect after ingestion because the peptide was stable to digestive protease and heat treatment in vitro. Copyright © 2008 Society of Chemical Industry     

The peptides in oat and malt extracts that are preferentially absorbed by Lactobacillus plantarum and stimulates its proliferation in milk

Lactobacillus plantarum proliferates inefficiently in milk, mainly because of its lack of cell envelope proteases and its inability to hydrolyse proteins in milk. Our previous study showed that this strain could grow well in milk with the addition of oat and malt extracts. To investigate the usage and preference for polypeptides and oligopeptides for this strain, sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), o-phthaldialdehyde (OPA), high-performance liquid chromatography (HPLC), plate counting and other methods were used in this study. The results showed that proteins in fermented milk cannot be absorbed and utilised by L. plantarum, whereas polypeptides and oligopeptides provide available nitrogen sources for their growth. Short-chain peptides were more conducive to absorption and utilisation than long-chain peptides. In particular, peptides with molecular weights in the range of 200–1400 Da in the oat extract and 100–700 Da in the malt extract were preferentially absorbed and utilised.     

益生菌Lactobacillus helveticus 130B4在牛乳中的生长特性及其促长因子研究

将具有ACE抑制活性的乳酸菌Laaobacillus helveficus 130B4用于发酵乳制品中,研究其在还原脱脂乳中的生长特性,并探讨通过添加生长促进物质对Laaobadllus helveticus 130B4生长特性以及对ACE抑制活性的影响.结果表明,Lb.helveticus 13084菌株在还原脱脂乳培养基中生长较缓慢,产酸能力较弱,37℃培养36 h后的pH值为4.31,酸度达0.8%,活菌数为8.93 g-1;72 h后的pH值为3.45,酸度可以达到1.85%,活菌数达9.1 g-1;酵母浸膏、大豆肽、核酸关联物质对该菌株的产酸能力有一定的促进作用.     

Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus

The effect of peptides released during the fermentation of milk on the humoral immune system and on fibrosarcoma growth was studied. Lactobacillus helveticus was able to release peptidic compounds during milk fermentation due to its high proteolytic activity, as was shown by the degree of proteolysis and size-exclusion HPLC elution profiles. Three fractions of these compounds were separated and fed to mice during different periods (2, 5, and 7 d). The humoral immune response was assessed by following the number of IgA-secreting cells, and the antitumor activity was monitored by studying the regression of subcutaneously implanted fibrosarcomas. Feeding during 2 and 7 d with the medium-sized fraction (Fraction II) significantly increased the IgA-producing cells in the intestines, whereas feeding with the large compound fraction (Fraction I) during 5 d and the small compound fraction (Fraction III) during all three feeding periods provided similar increases. A double dose of Fraction II showed the highest IgA-producing cell count. The increase by Fraction III was shown to be caused by the presence of L-Tryptophan. Fraction II significantly decreased the size of fibrosarcoma when previously fed during 7 d, and feeding with Fraction I during 5 d decreased significantly its size after 35 d of growth. Although the mechanisms by which lactic acid bacteria enhance the immune system are not clear, this study clearly shows that bioactive compounds released in fermented milks contribute to the immunoenhancing and antitumor properties of these products. The release of bioactive peptides by lactic acid bacteria can have important implications on the modulation of the cellular immune response.     

Effects of nitrates and nitrites on Lactobacillus helveticus and Lactobacillus casei dairy cultures

 The aim of this work was to observe the effects of nitrites and nitrates on the titratable acidity of milk after addition of Lactobacillus helveticus (TX 121) and L. casei (CAD 154) dairy cultures and on the levels of nitrate and nitrite. After adding L. helveticus and nitrites the increasing concentrations of the latter brought about a marked decrease in titratable acidity. In milk containing 100 mg·kg^–1 nitrite the resulting concentration was 39.33 mg·kg^–1 NaNO₂. Nitrates caused a less obvious decrease in titratable acidity, giving 13.27 g·l^–1 lactic acid. In milk containing 100 mg·kg^–1 NaNO₃ the resulting concentration was 24.99 mg·kg^–1 NaNO₃. Experiments with L. casei and a nitrite additive revealed a decrease in titratable acidity to 8.89 g·l^–1 lactic acid. After incubation, nitrite levels were reduced from 100 mg·kg^–1 NaNO₂ to 37.81 mg·kg^–1 NaNO₂. Nitrates were also stated to inhibit the titratable acidity of the sample, which decreased to 11.42 g·l^–1 lactic acid. Nitrates were reduced to 46.99 mg·kg^–1 NaNO₃. The present study shows that nitrites, more than nitrates decrease the titratable acidity of milk after addition of L. helveticus and L. casei dairy cultures. A reduction of nitrates and nitrites in milk samples by Lactobacillus was also found. The results of this study can be used in the dairy industry in the production of several types of hard cheese as well as fermented milk products that use L. helveticus and L. casei dairy cultures. Received: 31 March 1999 / Revised version: 6 September 1999     

热激修饰对瑞士乳杆菌细胞性质的影响

根据瑞士乳杆菌生理特性,优化了其最佳生长条件:接种量2%,温度40℃,初始pH值7.1,培养时间12 h。在此条件下培养,菌液浓度可达108~109mL-1。探讨了瑞士乳杆菌特性与热激温度、时间的相关性。结果表明,低于67℃或时间少于15 s,对抑制细胞产酸无明显影响;高于69℃或时间超过20 s,胞内酶残留率不足20%,优化出热激条件为温度67~69℃,时间15~20 s。